BDSX

Biodesix Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth 6/10
  • Value 3/10
Biodesix sales and earnings growth
BDSX Growth
Good
  • Revenue Y/Y 24.08%
  • EPS Y/Y 29.67%
  • FCF Y/Y 54.55%
Biodesix gross and profit margin trends
BDSX Profitability
Neutral
  • Gross margin 81.10%
  • EPS margin -39.80%
  • ROIC 5Y -71.18%
Biodesix net debt vs free cash flow
BDSX Risk
Poor
  • Debt / Equity 999.0
  • Debt / FCF 2.3
  • Interest coverage -3.6

Biodesix stock is less volatile than the overall market, so it's low risk. We give it a Poor risk rating.

More Diagnostics & Research stocks ↗